Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2a Study of LON002 (Sublingual Artemether Spray) in Subjects With Advanced Solid Tumours.

NCT02263950 is registered in ClinicalTrials.gov with LondonPharma Ltd. as lead sponsor.

NCT NCT02263950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02263950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2a Study of LON002 (Sublingual Artemether Spray) in Subjects With Advanced Solid Tumours.
Lead sponsor
LondonPharma Ltd.
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 31, 2014
Completion date
October 31, 2016
Enrollment
87 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumours